Skip to main content
SpringerLink
Log in

Functional Imaging of Gallbladder and Biliary Malignancies

  • Chapter
  • First Online:
Functional Imaging in Oncology

  • 1685 Accesses

Abstract

Functional imaging techniques are useful during diagnosis and evaluation of cholangiocarcinoma and gallbladder carcinoma. They are accurate, noninvasive, robust modalities useful for staging and determining resectability. Response to novel targeted therapies can also be assessed with newer imaging tools. Metabolic and molecular assessment and exploration of other functional parameters such as diffusion of water by means of MRI are becoming the new imaging paradigm in the evaluation of biliary tract malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

18F-FDG:

18F-fluoro-2-deoxy-d-glucose

ADC:

Apparent diffusion coefficient

CA 19-9:

Carbohydrate antigen 19-9

CEA:

Carcinoembriogenic antigen

CHC:

Cholangiocarcinoma

DWI:

Diffusion-weighted imaging

EHCCA:

Extracelullar cholangiocarcinoma

GBC:

Gallbladder carcinoma

MRC:

Magnetic resonance cholangiography

MRI:

Magnetic resonance imaging

MRS:

Magnetic resonance spectroscopy

PET:

Positron emission tomography

PET-CT:

Positron emission tomography computed tomography

PSC:

Primary sclerosing cholangitis

SUV:

Standardized uptake value

VEGF:

Vascular endothelial growth factor

References

  1. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006;3:33–42.

    Article  PubMed  Google Scholar 

  2. Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol. 1999;10:308–11.

    Article  PubMed  Google Scholar 

  3. Ralphs S, Khan SA. The role of the hepatitis viruses in cholangiocarcinoma. J Viral Hepat. 2013;20:297–305.

    Article  CAS  PubMed  Google Scholar 

  4. Chang KY, et al. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Comput Cancer Network. 2009;7:423–7.

    Google Scholar 

  5. Levi S, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 1991;51:3497–502.

    CAS  PubMed  Google Scholar 

  6. Han J, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics. 2002;1:173–87.

    Article  Google Scholar 

  7. Chung Y, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29:683–700.

    Article  PubMed  Google Scholar 

  8. Sainani N, et al. Cholangiocarcinoma: current and novel imaging techniques. Radiographics. 2008;5:1263–87.

    Article  Google Scholar 

  9. Menias C, et al. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 2008;4:1115–29.

    Article  Google Scholar 

  10. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Imaging. 1991;7:1–30.

    Google Scholar 

  11. Sugahara T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999;9:53–6.

    Article  CAS  PubMed  Google Scholar 

  12. Park SW, et al. Single shot fast spin echo diffusion-weighted MR imaging of the spine: is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema? Clin Imaging. 2004;28:102–8.

    Article  PubMed  Google Scholar 

  13. Koh DM, Collins D. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.

    Article  PubMed  Google Scholar 

  14. Randi G, et al. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.

    Article  CAS  PubMed  Google Scholar 

  15. Khan ZR, et al. Risk factors for biliary tract cancers. Am J Gastroenterol. 1999;94:149–52.

    Article  CAS  PubMed  Google Scholar 

  16. Strom BL, et al. Risk factors for gallbladder cancer: an international collaborative case–control study. Cancer. 1995;76:1747–56.

    Article  CAS  PubMed  Google Scholar 

  17. House M, et al. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 2003;10:882.

    Article  PubMed  Google Scholar 

  18. Rooholamini S, et al. Imaging of gallbladder carcinoma. Radiographics. 1994;2:291–306.

    Article  Google Scholar 

  19. Levy A, et al. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;2:295–314.

    Article  Google Scholar 

  20. Reinhardt M, et al. Detection of Klatskin’s tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med. 2005;46:1158–63.

    PubMed  Google Scholar 

  21. Laverman P, et al. [(18)F] FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma. Hepatol Res. 2007;37:127–32.

    Article  CAS  PubMed  Google Scholar 

  22. Prytz H, et al. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology. 2006;44:6.

    Article  Google Scholar 

  23. Fritscher-Ravens A, et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun. 2001;2:1277–85.

    Article  Google Scholar 

  24. Anderson C, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–7.

    Article  PubMed  Google Scholar 

  25. Ramos-Font C, et al. Positron tomography with 18F-fluorodeoxyglucose in the preoperative evaluation of gall bladder lesions suspicious of malignancy diagnostic utility and clinical impact. Rev Esp Med Nucl. 2011;30:267–75.

    Article  CAS  PubMed  Google Scholar 

  26. Lee J, et al. Risk stratification of gallbladder polyps (1–2 cm) for surgical intervention with 18F-FDG PET/CT. J Nucl Med. 2012;53:353–8.

    Article  CAS  PubMed  Google Scholar 

  27. Kumar R, et al. Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma. Clin Nucl Med. 2012;37:431–5.

    Article  PubMed  Google Scholar 

  28. Gowda GA. Human bile as a rich source of biomarker for hepatopancreatobiliary cancers. Biomark Med. 2010;4:299–314.

    Article  CAS  PubMed  Google Scholar 

  29. Albion N, et al. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis. Acta Radiol. 2008;49:855–62.

    Article  Google Scholar 

  30. Khan S, et al. Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol. 2005;17:733–8.

    Article  CAS  PubMed  Google Scholar 

  31. Nishijima T, et al. Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary disease. Jpn J Clin Oncol. 1997;27:13–7.

    Article  CAS  PubMed  Google Scholar 

  32. Wen H, et al. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol. 2010;52:228–33.

    Article  CAS  PubMed  Google Scholar 

  33. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics. 2009;29:1797–810.

    Article  PubMed  Google Scholar 

  34. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.

    Article  PubMed  Google Scholar 

  35. Cui XY, Chen HW. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol. 2010;16:3196–201.

    Article  PubMed  Google Scholar 

  36. Lee NK, et al. Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging. World J Gastroenterol. 2012;18:4102–17.

    Article  PubMed  Google Scholar 

  37. Cui XY, et al. Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma. Eur J Radiol. 2012;81:2961–5.

    Article  PubMed  Google Scholar 

  38. Patterson DM, et al. Technology insight: water diffusion MRI – a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol. 2008;5:220.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Body Section, Centro de Diagnóstico Enrique Rossi, Buenos Aires, Argentina

    Mariano Volpacchio & Joaquina López Moras

Authors
  1. Mariano Volpacchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joaquina López Moras
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariano Volpacchio .

Editor information

Editors and Affiliations

  1. Health Time Group, Jaén, Spain

    Antonio Luna

  2. Clinica Girona Hospital Sta. Caterina, Gerona, Spain

    Joan C. Vilanova

  3. CDPI and IRM, Botafongo - Rio de Janeiro/RJ, Brazil

    L. Celso Hygino Da Cruz Jr.

  4. Centro de Diagnóstico Dr. Enrique Rossi, Buenos Aires, Argentina

    Santiago E. Rossi

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Volpacchio, M., Moras, J.L. (2014). Functional Imaging of Gallbladder and Biliary Malignancies. In: Luna, A., Vilanova, J., Hygino Da Cruz Jr., L., Rossi, S. (eds) Functional Imaging in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40582-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40582-2_20

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40581-5

  • Online ISBN: 978-3-642-40582-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation